Most cited papers from AIDS Vancouver

AIDS Vancouver

What are the most cited papers from AIDS Vancouver?

The most cited paper from AIDS Vancouver is "Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies" (‡, 2008), with 1,683 citations. Next come "Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies" (1,531) and "Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada" (1,436).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 233 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies ‡ · The Lancet Open access	Jul 2008	1,683
2	Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies Matthias Egger, MARGARET T. MAY, Geneviève Chêne et al. · The Lancet	Jul 2002	1,531
3	Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada Hasina Samji et al. · PLoS ONE Open access	18 Dec 2013	1,436
4	Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review Bradley M. Mathers, Louisa J Degenhardt, Benjamin W. Phillips et al. · The Lancet Review	25 Sep 2008	1,293
5	Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology Wayne Delport, Art F. Y. Poon, Simon D. W. Frost et al. · Bioinformatics Open access	29 Jul 2010	1,242
6	Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival Mari M. Kitahata et al. · New England Journal of Medicine Open access	Apr 2009	1,110
7	Global epidemiology of HIV among female sex workers: influence of structural determinants Kate Shannon, Steffanie Ann Strathdee, Shira Miriam Goldenberg et al. · The Lancet Open access	21 Jul 2014	908
8	Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy Robert S. Hogg · JAMA	11 Feb 1998	869
9	Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators Edward J. Mills, Jean Bisimwa Nachega, David R. Bangsberg et al. · PLoS Medicine ReviewOpen access	16 Nov 2006	825
10	Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study Julio S. G. Montaner, Viviane Dias Lima, Rolando Barrios et al. · The Lancet Open access	17 Jul 2010	785
11	Treeio: An R Package for Phylogenetic Tree Input and Output with Richly Annotated and Associated Data Ligen Wang, Tommy Tsan‐Yuk Lam, Shuangbin Xu et al. · Molecular Biology and Evolution Open access	18 Oct 2019	751
12	Global Distribution and Conservation of Evolutionary Distinctness in Birds Walter Jetz, Gavin Huw Thomas, Jeffrey B. Joy et al. · Current Biology Open access	10 Apr 2014	654
13	Public health and international drug policy Joanne Csete et al. · The Lancet Open access	24 Mar 2016	640
14	Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence Thomas Santo, Brodie Clark, Matthew Hickman et al. · JAMA Psychiatry Open access	2 Jun 2021	618
15	Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients Hélène C. F. Côté, Zabrina L. Brumme, Kevin J.P. Craib et al. · New England Journal of Medicine Open access	14 Mar 2002	577
16	The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic Julio S. G. Montaner, Robert S. Hogg, Evan Wood et al. · The Lancet	Aug 2006	559
17	Validating a Shortened Depression Scale (10 Item CES-D) among HIV-Positive People in British Columbia, Canada Wendy Zhang, Nadia O’Brien, Jamie I. Forrest et al. · PLoS ONE Open access	19 Jul 2012	558
18	Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America Michael Jonah Silverberg et al. · Clinical Infectious Diseases Open access	30 Jan 2012	523
19	Barriers to Use of Free Antiretroviral Therapy in Injection Drug Users Steffanie Ann Strathdee · JAMA	12 Aug 1998	523
20	Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals Natasha K. Martin, Peter T. Vickerman, Jason Grebely et al. · Hepatology Open access	28 Mar 2013	505
21	Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work Kate Shannon, Thomas H Kerr, Shari Allinott et al. · Social Science & Medicine	26 Dec 2007	493
22	Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study Brandon D. L. Marshall, M‐J Milloy, Evan Wood et al. · The Lancet	Apr 2011	490
23	Adaptation of HIV-1 to human leukocyte antigen class I Yuka Kawashima et al. · Nature Open access	25 Feb 2009	480
24	Predictors of HIV Drug‐Resistance Mutations in a Large Antiretroviral‐Naive Cohort Initiating Triple Antiretroviral Therapy P. Richard Harrigan, Robert S. Hogg, Winnie W. Y. Dong et al. · The Journal of Infectious Diseases Open access	12 Jan 2005	432
25	The emergence of SARS-CoV-2 in Europe and North America Michael Worobey, Jonathan E. Pekar, Brendan B. Larsen et al. · Science Open access	10 Sep 2020	431
26	Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up Robert S. Hogg, Katherine Heath, David R. Bangsberg et al. · AIDS	May 2002	428
27	Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda Edward J. Mills, Celestin Bakanda, Josephine Birungi et al. · Annals of Internal Medicine	16 Aug 2011	418
28	Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021 Steven G. Deeks et al. · Nature Medicine Open access	30 Nov 2021	386
29	Influence of HLA-C Expression Level on HIV Control Richard Apps et al. · Science Open access	4 Apr 2013	385
30	Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting Julio S. G. Montaner, Viviane Dias Lima, P. Richard Harrigan et al. · PLoS ONE Open access	12 Feb 2014	361
31	Adverse effects of antiretroviral therapy for HIV infection. Valentina Montessori, Natasha Press, Marianne Harris et al. · PubMed Open access	20 Jan 2004	361
32	Global priorities for conserving the evolutionary history of sharks, rays and chimaeras R. William Stein, Christopher G. Mull, Tyler S. Kuhn et al. · Nature Ecology & Evolution	15 Jan 2018	358
33	Depression, Alcohol Use and Adherence to Antiretroviral Therapy in Sub-Saharan Africa: A Systematic Review Etheldreda Nakimuli‐Mpungu, Judith Bass, Pierre K. Alexandre et al. · AIDS and Behavior Review	24 Nov 2011	344
34	Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study Evan Wood, Thomas H Kerr, Brandon D. L. Marshall et al. · BMJ Open access	30 Apr 2009	343
35	Effect of drug law enforcement on drug market violence: A systematic review Dan Werb, Greg Rowell, Gordon Henry Guyatt et al. · International Journal of Drug Policy Review	Mar 2011	338
36	Cumulative Incidence of Cancer Among Persons With HIV in North America Michael Jonah Silverberg et al. · Annals of Internal Medicine Open access	5 Oct 2015	332
37	The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis Plan Victor DeGruttola et al. · Antiviral Therapy Open access	2000	330
38	Hospitals as a ‘risk environment’: An ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs Ryan McNeil, Will Small, Evan Wood et al. · Social Science & Medicine Open access	19 Jan 2014	323
39	Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration Rami Kantor et al. · PLoS Medicine Open access	19 Apr 2005	319
40	Adherence–resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness David R. Bangsberg, Edward P. Acosta, Reena Gupta et al. · AIDS	5 Jan 2006	316
41	Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic Nadia S. Fairbairn, Phillip Oliver Coffin, Alexander Yale Walley · International Journal of Drug Policy Open access	4 Jul 2017	294
42	Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy Viviane Dias Lima, Robert S. Hogg, P. Richard Harrigan et al. · AIDS	19 Mar 2007	282
43	Mapping 123 million neonatal, infant and child deaths between 2000 and 2017 Roy Burstein et al. · Nature Open access559 authors	16 Oct 2019	280
44	Molecular and Clinical Epidemiology of CXCR4‐Using HIV‐1 in a Large Population of Antiretroviral‐Naive Individuals Zabrina L. Brumme, James Goodrich, Howard Mayer et al. · The Journal of Infectious Diseases Open access	6 Jul 2005	271
45	Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort Zachary Tanner, Nathan J. Lachowsky, Erin Ding et al. · BMC Infectious Diseases Open access	20 Oct 2016	270
46	Mapping violence and policing as an environmental–structural barrier to health service and syringe availability among substance-using women in street-level sex work Kate Shannon, Melanie Rusch, Jean Shoveller et al. · International Journal of Drug Policy	22 Jan 2008	266
47	“They treated me like crap and I know it was because I was Native”: The healthcare experiences of Aboriginal peoples living in Vancouver's inner city Ashley Goodman, Kim Fleming, Nicole Markwick et al. · Social Science & Medicine Open access	26 Jan 2017	264
48	Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs Alexander Caudarella, Huiru Dong, M‐J Milloy et al. · Drug and Alcohol Dependence Open access	26 Feb 2016	263
49	Patient and family involvement in adult critical and intensive care settings: a scoping review Michelle Olding, Sarah E. McMillan, Scott Reeves et al. · Health Expectations Open access	7 Sep 2015	261
50	Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users Cari L. Miller, Caitlin L. Johnston, Patricia M. Spittal et al. · Hepatology Open access	Sep 2002	260

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.